- Leadership
- Program
- 2024 Program at a Glance
- 2023 Head & Neck Oncology Session
- 2023 GI Cancer Session
- 2023 Immuno Oncology Session
- 2023 Breast Imaging / Breast Surgical
- 2023 Breast Cancer Session
- 2023 Lung Cancer Session
- 2023 Uro Oncology Session
- 2023 Oncology Nursing Session
- 2023 Oncology Nutrition Session
- 2023 Palliative Care Session
- 2023 APMEA MTB Session
- 2023 Congress E-Brochure
- Speakers
- Partners
- Media
- Contact
- Webinars
- Journal Club
- About
- Upcoming JC
- Past Archived JC's
- 2024
- 2023
- February 13th Edition
- February 22nd Edition
- February 28th Edition
- March 6th Edition
- March 20th Edition
- April 17th Edition
- May 08th Edition
- May 17th Edition
- May 29th Edition
- June 12th Edition
- June 22nd Edition
- June 23rd Edition
- August 14th Edition
- September 7th Edition
- September 18th Edition
- October 16th Edition
- November 23rd Edition
- December 12th Edition
- 2022
- 2021
- 2020
- In Conversation
- In Conversation Series
- Journal Club
- Register Now
- Day 3 Access
- Young Leaders in Oncology
- Submit Interest
Sanjay Popat
Medical Oncologist, UK
Professor Popat has both a private and an NHS practice at The Royal Marsden. Professor Sanjay Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London.
He is a specialist thoracic oncologist, and is an internationally recognised expert in the treatment of lung cancer, mesothelioma and cancers of the thymus (thymoma and thymic carcinoma). Sanjay qualified from Guy’s and St Thomas’ Hospitals in 1994, completed general medical training at the Royal Brompton and the Hammersmith Hospital, and medical oncology training at The Royal Marsden. He was awarded a PhD in Molecular Genetics in 2002 and thereafter undertook a postdoctoral Clinician Scientist Fellowship, and subsequently a HEFCE Clinical Senior Lectureship. He has published in the fields of molecular genetics, therapeutic biomarkers and medical oncology. He has been awarded nationally and internationally competitive prizes for his research, in addition to four research fellowships.